真人百家家乐app下载home » Soliton announces public offering
SOLY) announced that it intends to offer an undisclosed amount of shares of its common stock in an underwritten public offering.
The Houston-based medical device company also intends to grant underwriters a 30-day option to purchase up to an additional 15% of the number of shares offered.
Cantor Fitzgerald & Co. is acting as the sole book-running manager for the proposed offering, according to a news release.
Soliton develops an FDA-cleared device that uses rapid pulses of acoustic shockwaves as an accessory to lasers for the removal of unwanted tattoos. It is engaged in bringing the Rapid Acoustic Pulse device to the market and completed a clinical study using the system to improve the appearance of cellulite.